LumiraDx Appoints Administrators, Sells Platform to Roche

LumiraDx Limited announced the appointment of joint administrators and the sale of its point of care platform to Roche for $295 million.

• Andrew Johnson, Lisa Rickelton and Lindsay Hallam of FTI Consulting LLP have been appointed as joint administrators of two of its subsidiaries, LumiraDx Group Limited and LumiraDx International Limited, which together hold substantially all of the assets of the LumiraDx group
• Roche to acquire point of care diagnostics platform business and certain related assets for $295m plus $55m for the reimbursement of amounts to fund business until closing of deal
• Expected to close mid 2024
• Proceeds to be ...